Dr. Sager is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
181 Pleasant St
Newton, MA 02459Phone+1 844-724-3591Fax+1 844-724-3590- Is this information wrong?
Summary
- Guiding cancer patients (adults and children alike) to access innovative therapies that maximize longevity and quality of life.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2000 - 2003- Johns Hopkins UniversityResidency, Pediatrics, 1999 - 2000
Children's Hospital Los AngelesResidency, Pediatrics, 1997 - 1999
Weill Cornell MedicineClass of 1997
Clinical Trials
- Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer Start of enrollment: 2018 Sep 20
- Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma Start of enrollment: 2019 Jan 08
Publications & Presentations
PubMed
- 126 citationsA Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced MalignanciesD. Ross Camidge, Roy S. Herbst, Michael S. Gordon, S. Gail Eckhardt, Razelle Kurzrock, Blythe Durbin, Josephine Ing, Tanyifor M. Tohnya, Jason Sager, Avi Ashkenazi, Go...> ;Clinical Cancer Research. 2010 Feb 15
- 22 citationsDiscodermolide analogues as the chemical component of combination bacteriolytic therapy.Amos B. Smith, B. Scott Freeze, Matthew J. LaMarche, Jason Sager, Kenneth W. Kinzler, Bert Vogelstein> ;Bioorganic & Medicinal Chemistry Letters. 2005 Aug 1
- 9 citationsIdentification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine–resistant cancer cellsKurtis E. Bachman, Jason Sager, Ian Cheong, Marco Catto, Alberto Bardelli, Ben Ho Park, Bert Vogelstein, Angelo Carotti, Kenneth W. Kinzler, Christoph Lengauer> ;Molecular Cancer Therapeutics. 2005 Jun 1
- Join now to see all
Press Mentions
Ikena Oncology Appoints Dr. Sergio Santillana, MD, MSc, MBA as Chief Medical OfficerAugust 18th, 2020
Ikena Oncology Announces Publication in Nature Communications of Preclinical Data Supporting the Therapeutic Potential of AHR BlockadeAugust 12th, 2020
Kyn Therapeutics Strengthens Leadership Team with Key AppointmentsMay 7th, 2019
External Links
- Sagely Healthhttps://www.sagelyhealth.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
